Haleon Is Maintained at Overweight by Morgan Stanley
Haleon Analyst Ratings
Haleon PLC (HLN) Receives a Buy From Jefferies
Bank of America Securities Remains a Buy on Haleon PLC Sponsored ADR (HLN)
Berenberg Initiates Haleon at Buy With $11.44 Price Target
Haleon PLC: Solid Performance Balanced With Premium Valuation Leads to Neutral Rating
Haleon PLC: A Strong Buy on Resilient Growth and Robust Shareholder Returns
Kepler Capital Remains a Hold on Haleon PLC (HLN)
Barclays Keeps Their Buy Rating on Haleon PLC (HLN)
Haleon PLC: A Hold Rating Amid Solid Fundamentals and Cautious Optimism
Haleon Now Expects 2024 Operating Profit Growth to Grow High-Single Digit
Analysts Offer Insights on Healthcare Companies: Centene (CNC), Haleon PLC (GB:HLN) and Ultragenyx Pharmaceutical (RARE)
Haleon PLC (HLN) Gets a Buy From Barclays
Analysts' Opinions Are Mixed on These Healthcare Stocks: Haleon PLC (GB:HLN) and Stoke Therapeutics (STOK)
Haleon Analyst Ratings
Haleon Analyst Ratings
Credit Suisse Lifts Price Target on Haleon to GBP3.90 From GBP3.72 on 'Strong' Underlying Trends, Pricing; Outperform Rating Kept
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), UnitedHealth (UNH) and Haleon PLC Sponsored ADR (HLN)
Haleon Analyst Ratings
Haleon analyst ratings
No Data
No Data